대한부인종양학회

최신 논문

총 게시글 : 33

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors. 2025-03-20 VIEW : 2
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY). 2025-03-20 VIEW : 0
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial. 2025-03-20 VIEW : 0
Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results. 2025-03-20 VIEW : 2
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial. 2025-03-20 VIEW : 4
Vulvar Carcinoma: Standard of Care and Perspectives 2024-06-26 VIEW : 10
Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial 2024-06-26 VIEW : 3
Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center 2024-03-29 VIEW : 28
Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients 2024-03-29 VIEW : 12
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement 2024-03-29 VIEW : 12
Reducing Unnecessary Oophorectomies for Benign Ovarian Neoplasms in Pediatric Patients 2023-12-26 VIEW : 4
Safety and antitumour activity of cadonilimab, an anti- PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial 2023-12-26 VIEW : 3
Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update 2023-09-19 VIEW : 52
Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations 2023-09-19 VIEW : 16
Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Updaterns 2023-06-29 VIEW : 19

1
2
3